MedPath

TOlerance MOlecular and Genome-wide Studies With Renal Allograft Recipient Material

Not Applicable
Completed
Conditions
Kidney Transplantation
Interventions
Genetic: High throughput DNA and RNA sequencing
Registration Number
NCT05124444
Lead Sponsor
Université Libre de Bruxelles
Brief Summary

TOMOGRAM is a European multicentric, prospective, experimental, controlled study that aims to increase our understanding of the causative mechanisms of operational tolerance in kidney transplantation through the achievement of several multimodal whole-genomic analysis in human biological samples.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • recipient of an allogenic renal allograft,
  • have experienced (whatever ongoing or not) at least a whole year with blood creatinine <1.7 mg/dL and proteinuria </=1g/day or /g creatinine despite the COMPLETE discontinuation of immunosuppressive drugs,
  • alternatively, have experienced (whatever ongoing or not) at least a whole year with stable blood creatinine (max 20% variation) and proteinuria above these criteria despite the COMPLETE discontinuation of immunosuppressive drugs
Exclusion Criteria
  • Past medical history of allogeneic bone-marrow transplantation / combined organ transplantation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cases (tolerant patients)High throughput DNA and RNA sequencing-
ControlsHigh throughput DNA and RNA sequencing-
Primary Outcome Measures
NameTimeMethod
Number of moderately to highly damaging exonic variantsThrough study completion, an average of 2 year
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath